Literature DB >> 17920787

Ketamine exposure in adult mice leads to increased cell death in C3H, DBA2 and FVB inbred mouse strains.

Chalon R Majewski-Tiedeken1, Cara R Rabin, Steven J Siegel.   

Abstract

BACKGROUND: Drug abuse is common among adolescents and young adults. Although the consequences of intoxication are known, sequelae of drugs emerging on campuses and in clubs nationwide are not. We previously demonstrated that ketamine exposure results in lasting physiological abnormalities in mice. However, the extent to which these deficits reflect neuropathologic changes is not known.
METHODS: The current study examines neuropathologic changes following sub-anesthetic ketamine administration (5mg/kg i.p. x 5) to three inbred mouse strains. Stereologic quantification of silver stained nuclear and linear profiles as well as activated caspase-3 labeling was used to address: (1) whether or not ketamine increases excitotoxic and apoptotic cell death in hippocampal CA3 and (2) whether or not ketamine-induced cell death varies by genetic background.
RESULTS: Ketamine increased cell death in hippocampal CA3 of adult C3H, DBA2 and FVB mice. Neither silver staining nor activated caspase-3 labeling varied by strain, nor was there an interaction between ketamine-induced cell death and strain.
CONCLUSIONS: Ketamine exposure among young adults, even in limited amounts, may lead to irreversible changes in both brain function and structure. Loss of CA3 hippocampal cells may underlie persistent ERP changes previously shown in mice and possibly contribute to lasting cognitive deficits among ketamine abusers.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17920787      PMCID: PMC2234578          DOI: 10.1016/j.drugalcdep.2007.08.009

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  94 in total

1.  Impairment of conditioned contextual fear of C57BL/6J mice by intracerebral injections of the NMDA receptor antagonist APV.

Authors:  O Stiedl; K Birkenfeld; M Palve; J Spiess
Journal:  Behav Brain Res       Date:  2000-12-05       Impact factor: 3.332

2.  Traumatic compaction of the axonal cytoskeleton induces argyrophilia: histological and theoretical importance.

Authors:  F Gallyas; O Farkas; M Mázló
Journal:  Acta Neuropathol       Date:  2002-01       Impact factor: 17.088

3.  Calpain activation and alpha-spectrin cleavage in rat brain by ethanol.

Authors:  Yadavalli Rajgopal; Mohan C Vemuri
Journal:  Neurosci Lett       Date:  2002-03-22       Impact factor: 3.046

4.  An improved cupric-silver method for impregnation of axonal and terminal degeneration.

Authors:  J S DeOlmos; W R Ingram
Journal:  Brain Res       Date:  1971-10-29       Impact factor: 3.252

5.  Low doses of memantine disrupt memory in adult rats.

Authors:  Catherine Creeley; David F Wozniak; Joanne Labruyere; George T Taylor; John W Olney
Journal:  J Neurosci       Date:  2006-04-12       Impact factor: 6.167

Review 6.  The enigma of fetal alcohol neurotoxicity.

Authors:  John W Olney; David F Wozniak; Nuri B Farber; Vesna Jevtovic-Todorovic; Petra Bittigau; Chrysanthy Ikonomidou
Journal:  Ann Med       Date:  2002       Impact factor: 4.709

7.  Concurrent use of methamphetamine, MDMA, LSD, ketamine, GHB, and flunitrazepam among American youths.

Authors:  Li-Tzy Wu; William E Schlenger; Deborah M Galvin
Journal:  Drug Alcohol Depend       Date:  2006-02-17       Impact factor: 4.492

8.  Ethanol-induced alteration in N-methyl-D-aspartate receptor 2A C-terminus and protein kinase C activity in rat brain.

Authors:  Rukhsana Sultana; Phanithi Prakash Babu
Journal:  Neurosci Lett       Date:  2003-09-25       Impact factor: 3.046

9.  Small-dose ketamine improves the postoperative state of depressed patients.

Authors:  Akira Kudoh; Yoko Takahira; Hiroshi Katagai; Tomoko Takazawa
Journal:  Anesth Analg       Date:  2002-07       Impact factor: 5.108

10.  Dentate gyrus NMDA receptors mediate rapid pattern separation in the hippocampal network.

Authors:  Thomas J McHugh; Matthew W Jones; Jennifer J Quinn; Nina Balthasar; Roberto Coppari; Joel K Elmquist; Bradford B Lowell; Michael S Fanselow; Matthew A Wilson; Susumu Tonegawa
Journal:  Science       Date:  2007-06-07       Impact factor: 47.728

View more
  15 in total

1.  CD-1 and Balb/cJ mice do not show enduring antidepressant-like effects of ketamine in tests of acute antidepressant efficacy.

Authors:  Anita J Bechtholt-Gompf; Karen L Smith; Catherine S John; Hannah H Kang; William A Carlezon; Bruce M Cohen; Dost Ongür
Journal:  Psychopharmacology (Berl)       Date:  2011-01-28       Impact factor: 4.530

Review 2.  Glutamate receptor antagonists as fast-acting therapeutic alternatives for the treatment of depression: ketamine and other compounds.

Authors:  Mark J Niciu; Ioline D Henter; David A Luckenbaugh; Carlos A Zarate; Dennis S Charney
Journal:  Annu Rev Pharmacol Toxicol       Date:  2014       Impact factor: 13.820

3.  Assessment of NMDA receptor NR1 subunit hypofunction in mice as a model for schizophrenia.

Authors:  T B Halene; R S Ehrlichman; Y Liang; E P Christian; G J Jonak; T L Gur; J A Blendy; H C Dow; E S Brodkin; F Schneider; R C Gur; S J Siegel
Journal:  Genes Brain Behav       Date:  2009-05-08       Impact factor: 3.449

4.  Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement.

Authors:  Anna Papazoglou; Andreas Lundt; Carola Wormuth; Dan Ehninger; Christina Henseler; Julien Soós; Karl Broich; Marco Weiergräber
Journal:  J Vis Exp       Date:  2016-06-25       Impact factor: 1.355

5.  Juvenile exposure to ketamine causes delayed emergence of EEG abnormalities during adulthood in mice.

Authors:  R E Featherstone; L R Nagy; C G Hahn; S J Siegel
Journal:  Drug Alcohol Depend       Date:  2013-09-27       Impact factor: 4.492

6.  Pharmacokinetics of ketamine and xylazine in young and old Sprague-Dawley rats.

Authors:  Daphnée Veilleux-Lemieux; Aude Castel; Denise Carrier; Francis Beaudry; Pascal Vachon
Journal:  J Am Assoc Lab Anim Sci       Date:  2013-09       Impact factor: 1.232

7.  Novel environment and GABA agonists alter event-related potentials in N-methyl-D-aspartate NR1 hypomorphic and wild-type mice.

Authors:  Christina L Bodarky; Tobias B Halene; Richard S Ehrlichman; Anamika Banerjee; Rabindranath Ray; Chang-Gyu Hahn; Gerald Jonak; Steven J Siegel
Journal:  J Pharmacol Exp Ther       Date:  2009-07-14       Impact factor: 4.030

8.  Chronic ketamine impairs fear conditioning and produces long-lasting reductions in auditory evoked potentials.

Authors:  Laura C Amann; Tobias B Halene; Richard S Ehrlichman; Stephen N Luminais; Nan Ma; Ted Abel; Steven J Siegel
Journal:  Neurobiol Dis       Date:  2009-05-23       Impact factor: 5.996

9.  Anesthetic and pathological changes following high doses of ketamine and xylazine in Sprague Dawley rats.

Authors:  Marie-Chantal Giroux; Pierre Hélie; Patrick Burns; Pascal Vachon
Journal:  Exp Anim       Date:  2015-03-27

Review 10.  EEG Radiotelemetry in Small Laboratory Rodents: A Powerful State-of-the Art Approach in Neuropsychiatric, Neurodegenerative, and Epilepsy Research.

Authors:  Andreas Lundt; Carola Wormuth; Magdalena Elisabeth Siwek; Ralf Müller; Dan Ehninger; Christina Henseler; Karl Broich; Anna Papazoglou; Marco Weiergräber
Journal:  Neural Plast       Date:  2015-12-24       Impact factor: 3.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.